Insmed Appoints Donald J. Hayden, Jr.
as Executive Chairman
Donald J. Hayden
Mr. Hayden has served as Chairman of the Insmed Board of Directors since December 2010.
has a long record of success in the pharmaceutical and biotechnology industries, and his
insights and extensive executive-level experience will continue to be tremendous assets as we move forward with our growth and development initiatives."
"It is a privilege to have been asked by my fellow Board members to serve as Executive Chairman of
at this important stage of the Company's development," said
became Chairman of
following the merger with Transave
had previously served as Executive Chairman of Transave
since April 2006.
also currently serves as Lead Independent Director of Amicus Therapeutics
and Director of
. He also serves in Board roles for several privately-held companies, including Executive Chairman of
Mr. Hayden is also a senior advisor to
Prospect Venture Partners
, a venture capital firm.
From 1981 to 2006, he had a 25 year career with Bristol-Myers Squibb Company, where he served in key executive roles such as President of
Mr. Hayden holds a B.A. from